Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
Sequencing PARP vs Radioligand in BRCA2 Patients
Matthew favors PARP therapy for BRCA2-positive, PSMA-positive patients and avoids combining PARP with radioligand.
Play episode from 37:42
Transcript
